| Product Name | MF | CAS | Details |
|---|
| 4-Chloro-1-ethyl-5-methyl-1H-pyrazole | C6H9ClN2 | 1172915-66-0 | Details |
| Ethyl 5-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate hydrochloride | C9H9ClN2O3S | 1185295-18-4 | Details |
| {5-[(2,6-Dimethylmorpholin-4-yl)methyl]-1H-tetrazol-1-yl}acetic acid hydrochloride | C10H18ClN5O3 | 1185299-94-8 | Details |
| (2-{1-[(4-Fluorophenyl)sulfonyl]piperidin-4-yl}ethyl)amine Hydrochloride | C13H20ClFN2O2S | 1185298-49-0 | Details |
| 1-({1-[(3,5-Dimethylisoxazol-4-yl)sulfonyl]-piperidin-4-yl}acetyl)piperazine Hydrochloride | C16H27ClN4O4S | 1185302-54-8 | Details |
| Ethyl 6,8-dichloro-2-(trifluoromethyl)-2H-chromene-3-carboxylate | C13H9Cl2F3O3 | 1160474-53-2 | Details |
| 7-(tert-Butyl)-2,4-bis(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile | C13H10F6N4 | 1174652-30-2 | Details |
| Ethyl 5-amino-1-[4-bromo-3-(trifluoromethyl)-phenyl]-1H-pyrazole-4-carboxylate | C13H11BrF3N3O2 | 1186404-53-4 | Details |
| Methyl 4-amino-3-(benzyloxy)-5-iodobenzenecarboxylate | C15H14INO3 | 1186405-03-7 | Details |
| 7-(tert-Butyl)-2,4-bis(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide | C13H12F6N4O | 1186404-55-6 | Details |
| 2-[5-Methoxy-2-nitro-4-(trifluoromethyl)phenyl]-acetic acid | C10H8F3NO5 | 1190198-33-4 | Details |
| 3-(3-Aminomethyl-phenyl)-5-methyl-6,7-dihydro-5H-isoxazolo[4,5-c]pyridin-4-one Hydrochloride | C14H16ClN3O2 | 1185295-36-6 | Details |
| 7-Piperidin-3-yl-2-trifluoromethyl-[1,2,4]-triazolo[1,5-a]pyrimidine Hydrochloride | C11H13ClF3N5 | 1185134-92-2 | Details |
| N-nitroso Viloxazine | Details |
| Vorolanib Impurity 3 | 1013920-14-3 | Details |
| Vorolanib Impurity 4 | C22H24FN5O3 | 2767064-07-1 | Details |
| Vorolanib Impurity 4-d3 | Details |
| Glumetinib Impurity1 | 1642582-50-0 | Details |
| Glumetinib Impurity2 | 1642582-87-3 | Details |
| Glumetinib Impurity3 | 1642894-19-6 | Details |
| Glumetinib Impurity4 | 1642582-85-1 | Details |
| Glumetinib Impurity5 | C28H30N10O2S | 1642582-92-0 | Details |
| Glumetinib Impurity6 | 1642582-83-9 | Details |
| Glumetinib Impurity7 | 1642582-23-7 | Details |
| Glumetinib Impurity8 | 1642582-88-4 | Details |
| Glumetinib Impurity9 | 1642582-15-7 | Details |
| Glumetinib Impurity11 | C10H9N5 | 1642583-00-3 | Details |
| Glumetinib Impurity10 | C7H4Cl2N2O2S | 1642583-16-1 | Details |
| Glumetinib Impurity12 | C17H12ClN7O2S | 1642581-60-9 | Details |
| Glumetinib Impurity13 | C17H12BrN7O2S | 1642582-17-9 | Details |
| Glumetinib Impurity25 | 1642582-36-2 | Details |
| Glumetinib Impurity26 | 1642582-32-8 | Details |
| Glumetinib Impurity24 | 1642582-19-1 | Details |
| Glumetinib Impurity22 | 1642582-47-5 | Details |
| Glumetinib Impurity23 | 1642581-62-1 | Details |
| Glumetinib Impurity21 | 1642582-41-9 | Details |
| Glumetinib Impurity14 | C23H17N7O2S | 1642582-18-0 | Details |
| Glumetinib Impurity15 | 1642582-52-2 | Details |
| Glumetinib Impurity16 | 1642582-37-3 | Details |
| Glumetinib Impurity17 | 1642582-21-5 | Details |
| Glumetinib Impurity18 | 1642582-28-2 | Details |
| Glumetinib Impurity19 | 1642582-33-9 | Details |
| Glumetinib Impurity20 | 1642582-39-5 | Details |
| Febuxostat Impurity 78 | C16H16N2O3S | 2418591-43-0 | Details |
| Baloxavir Impurity | C17H17N3O4 | 2762066-94-2 | Details |
| Baricitinib Impurity 53 | C7H10N2O2S | 1187595-85-2 | Details |
| Baricitinib Impurity 55 | C8H12N2O2S | 2101302-47-8 | Details |
| Baricitinib Impurity 63 | C22H27N7O4S | 1187595-90-9 | Details |
| Baricitinib Impurity 66 | C12H14ClN3O2 | 1146629-75-5 | Details |
| Baricitinib Impurity 67 | C19H25N5O3 | 1146629-76-6 | Details |
| Baricitinib Impurity 19 | C5H7NO2 | 775271-06-2 | Details |
| Baricitinib Impurity 20 | 2964606-42-4 | Details |
| Baricitinib Impurity 27 | C13H15N5O | 1911644-33-1 | Details |
| Baricitinib Impurity 28 | C5H6N2 | 1315059-55-2 | Details |
| Baricitinib Impurity 29 | C22H31N7O3SSi | 1187594-13-3 | Details |
| Baricitinib Impurity 40 | C19H21N7O2 | 1269823-19-9 | Details |
| Baricitinib Impurity 43 | C5H9NO3S | 1401222-91-0 | Details |
| Baricitinib Impurity 48 | C17H20N6O4S | 2402776-80-9 | Details |
| Baricitinib Impurity 8 | C16H17N7O2S | 2514763-82-5 | Details |
| Baricitinib Impurity 11 | C23H27N9O4S2 | 2402776-84-3 | Details |
| Baricitinib Impurity 1 | C16H17N7O2S | 2402776-83-2 | Details |
| Baricitinib Impurity 6 | 2402776-81-0 | Details |
| Adapalene Impurity 25 | C17H22O | 726-94-3 | Details |
| Glumetinib Impurity27 | 1642582-46-4 | Details |
| Dapagliflozin Impurity 253 | C19H23ClO | 2133407-74-4 | Details |
| Biotin Impurity 8（Biotin EP Impurity G） | C22H25N2OS+ | 99297-09-3 | Details |
| Ibrutinib Impurity 13 | C27H30N6O3 | 1642571-08-1 | Details |
| Ibrutinib Impurity 31 | C25H24N6O3 | 2417548-74-2 | Details |
| Ibrutinib Impurity 65 | C21H20N6O | 330793-52-7 | Details |
| Ibrutinib Impurity 56 | C11H21NO3 | 2102325-71-1 | Details |
| Ibrutinib Impurity 67 | C26H29N7O3 | 1839099-44-3 | Details |
| Ibrutinib Impurity 66 | C26H28N6O2 | 1839099-23-8 | Details |
| Ibrutinib Impurity 68 | C26H29N7O3 | 1906970-60-2 | Details |
| Ibrutinib Impurity 69 | C25H26N6O3 | 2554619-82-6 | Details |
| Ruxolitinib Impurity 17 | C12H21N3O6 | 2761879-51-8 | Details |
| Ibrutinib Impurity 90 | C25H24N6O3 | 2052279-49-7 | Details |
| Ibrutinib Impurity 71 | C21H20N6O | 1418272-84-0 | Details |
| Ibrutinib Impurity 70 | C25H26N6O4 | 1288339-03-6 | Details |
| Melphalan Impurity 14 | C19H16N2O6 | 17451-67-1 | Details |
| Abiraterone Impurity 3（Abiraterone Acetate N-Oxide） | C26H33NO3 | 2517964-85-9 | Details |
| Abiraterone Impurity 4（Abiraterone N-Oxide） | C24H31NO2 | 2378463-76-2 | Details |
| Abiraterone Impurity 6（Abiraterone Acetate 3-Epi Impurity） | C26H33NO2 | 2484719-10-8 | Details |
| Abiraterone Impurity 40 | C28H38ClNO | 2484719-13-1 | Details |
| Abiraterone Impurity 60 | C30H40NO7+ | 2307194-35-8 | Details |
| Abiraterone Impurity 61 | C30H38NO7+ | 2307194-36-9 | Details |
| Abiraterone Impurity 69 | C26H35NO3 | 219843-78-4 | Details |
| Melphalan Impurity 10（Melphalan EP Impurity J） | C15H22Cl2N2O3 | 2724549-95-3 | Details |
| Melphalan Impurity 6（Melphalan EP Impurity F） | C13H18Cl4N2O2 | 2724878-98-0 | Details |
| Melphalan Impurity 5（Melphalan EP Impurity E） | Details |
| Ruxolitinib Impurity 10 | C17H20N6O | 2102675-42-1 | Details |
| Ruxolitinib Impurity 51 | C23H32N6OSi | 941685-41-2 | Details |
| Ruxolitinib Impurity 1 Phosphate（(S)-Ruxolitinib Phosphate） | C17H21N6O4P | 2703484-89-1 | Details |
| Abiraterone Impurity 70 | C26H33NO3 | 2484719-11-9 | Details |
| Perindopril Impurity 7（Perindopril EP Impurity K） | C12H18N2O2 | 2165676-00-4 | Details |
| Perindopril Impurity 27 | C10H19NO4 | 760127-31-9 | Details |
| Perindopril Impurity 44 (Perindopril EP Impurity AA) | C19H32N2O5 | 145513-32-2 | Details |
| Perindopril Impurity 35（Perindopril EP Impurity R） | C19H32N2O5 | 145513-31-1 | Details |
| Perindopril Impurity 37 (Perindopril EP Impurity T) | C19H32N2O5 | 145513-54-8 | Details |
| Perindopril Impurity 39 (Perindopril EP Impurity V) | C19H32N2O5 | 145513-36-6 | Details |
| 1-Pyrrolidinehexanoic acid, 2-ethenyl-γ,5-dioxo- | C12H17NO4 | 2512190-67-7 | Details |
| Pemafibrate Impurity 16 | C27H28N2O6 | 848260-34-4 | Details |
| Lercanidipine Impurity 14 | C14H12N2O5 | 102993-38-4 | Details |
| Nicardipine Impurity 22 | C26H29N3O7 | 2724510-66-9 | Details |
| Sorafenib Impurity 81 | C14H9ClF3NO2 | 871555-75-8 | Details |
| Sorafenib Impurity 85 | C7H6Cl2N2O | 1021077-12-2 | Details |
| Sorafenib Impurity 84 | C7H6Cl2N2O | 1403469-80-6 | Details |
| Sorafenib Impurity 94 | C8H7Cl3N2O | 1339547-50-0 | Details |
| Dapagliflozin Impurity 47 | C15H14BrClO2 | 1280647-32-6 | Details |
| Dapagliflozin Impurity 45 | C30H35ClO11 | 461432-28-0 | Details |
| Sorafenib Impurity 90 | C9H13N3O | 1863331-80-9 | Details |
| Sorafenib Impurity 93 | C21H16ClF3N4O3 | 1290546-48-3 | Details |
| Dapagliflozin Impurity 4 | C21H26O6 | 2452300-89-7 | Details |
| Lifitegrast Impurity 54 | C29H26N2O7S | 2295862-00-7 | Details |
| Product Total： Product Page： | ||||
| 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 | ||||